Ofev (nintedanib)

pCPA File Number: 21403
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic fibrosing interstitial lung diseases
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CDA-AMC Project Number:
SR0654-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: